
A study investigated the efficacy and tolerability of medications for attention-deficit hyperactivity disorder (ADHD) across age groups. The analysis covered 133 double-masked, randomized controlled trials involving children, adolescents, and adults. Medications such as amphetamines, methylphenidate, atomoxetine, bupropion, clonidine, guanfacine, and modafinil were compared to each other and placebo. Efficacy was assessed based on symptom severity ratings from teachers and clinicians, while tolerability was measured by the proportion of patients discontinuing due to side effects. Findings suggest that methylphenidate is preferred for children and adolescents, while amphetamines are preferred for adults, considering both efficacy and safety in short-term ADHD treatment.
Like
Save
Share